News

  • by Frank Vinluan
    Verastem Oncology developed its drug combination for low-grade serous ovarian cancer (LGSOC) driven by KRAS mutations. As the first treatment specifically approved for this rare cancer, clinicians expect it will become the new standard of care. The post Accelerated FDA Approval Makes Verastem Drug the First Therapy for Rare Type of Ovarian Cancer appeared first […]
  • by Marissa Plescia
    Through a new partnership, Babyscripts members now have access to Withings BPM Pro 2, an FDA-cleared cellular blood pressure monitor. The post Withings, Babyscripts Team Up to Tackle Hypertensive Disorders of Pregnancy appeared first on MedCity News.
  • by Katie Adams
    Trust in the U.S. healthcare system is eroding, but experts say rebuilding it is possible. They say this will require both payers and providers to prioritize empathy, transparency and personalized communication. The post Americans’ Trust in the Healthcare System Is Plummeting. How Can It Be Repaired? appeared first on MedCity News.
  • by Meg Dietzel
    Within the healthcare space, marketing can now be used for much more than increasing awareness and acquiring new patients; it can be a primary driver for ongoing patient retention and even a tool to improve patient outcomes.  The post Healthcare Marketing is Missing the Mark in Three Big Ways appeared first on MedCity News.
  • by Seth Cohen
    For the healthcare industry, this crisis isn’t just about financial risk — it’s about consumer trust. When patients can’t afford care, they disengage, often convinced the system isn’t built for them. And when trust erodes, so do outcomes — because people who don’t trust the system are less likely to seek care at all. The […]
  • by Frank Vinluan
    HAYA Therapeutics’ drugs hit targets in the dark genome, the part of the genome that does not code for proteins but plays a key role in regulating gene expression. With the Series A funding, the startup will enter Phase 1 with of a genetic medicine addressing fibrosis that leads to a type of heart failure. […]
  • by Katie Adams
    Cedars-Sinai and Redesign Health launched a new innovation center seeking to build digital health startups from the ground up. These startups will focus on four main areas: care access, personalized medicine, provider workflows and care coordination. The post Cedars-Sinai, Redesign Health Launch New Digital Health Startup Builder appeared first on MedCity News.
  • by Marissa Plescia
    During a recent panel, several employers shared the strategies they’ve implemented to support employees, including direct contracting and virtual support groups. The post How 4 Employers Are Supporting Workers Through Challenging Times appeared first on MedCity News.
  • by Nicole Clark
    Transparent communication, sensitivity to parental concerns, and clear explanations of procedures help boost trust and reduce anxiety for both the patient and the provider. The post Comprehensive Autism Diagnostic Evaluation: A Guide for Medical Professionals on Supporting Families appeared first on MedCity News.
  • by Luidgi Faubert
    [Sponsored] The health care sector is constantly operating, so patient miscommunication can occur at any time. Find out the top-rated companies that provide medical interpretation services. The post 10 Top-Rated Companies That Provide Medical Interpretation Services appeared first on MedCity News.
  • by Julian Herbert
    As AI has evolved to be more accurate and reliable, it’s become suitable for high-stakes use cases including automating health insurance verification. The post The Patient Intake Revolution – How AI Is Eliminating Intake Busywork and Reducing Insurance Denials appeared first on MedCity News.
  • by Stephanie Baum
    [Sponsored] A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they’re advising startups in the wake of cuts to NIH and SBIR grants. The post Get a Snapshot of the Early Stage Life Science Startup […]
  • by Marissa Plescia
    Employers should review their contracts, conduct claims analyses and more to meet their fiduciary responsibility, according to one expert. The post 7 Things Employers Should Be Doing to Fulfill Their Fiduciary Duty appeared first on MedCity News.
  • by Katie Adams
    Experts say the fallout from HHS’ restructuring could set public health efforts back by decades by dismantling critical infrastructure. It’s also important to note that these changes cast serious doubt on the future of interoperability, pointed out Jason Prestinario, CEO of data platform Particle Health. The post What Does HHS’ Restructuring Mean for Interoperability In […]
  • by Frank Vinluan
    Eli Lilly is licensing rights to a Phase 1-ready antibody that startup Alchemab developed for amyotrophic lateral sclerosis and other neurodegenerative disorders. Lilly’s pipeline has ALS drug candidates from previous deals with QurAlis and Verge Genomics. The post Eli Lilly Turns to Alchemab to Add Another AI-Discovered ALS Drug Prospect appeared first on MedCity News.
  • by Pat Youngblood
    Health insurance claims are a growing headache for providers; many say their employers could do more to help them address the daily demands of insurers The post How Healthcare Employers Can Do More To Help Providers Manage Payer Frustration appeared first on MedCity News.
  • by Kristin Haluch
    A very small percentage of health outcomes are tied to direct healthcare activities. The non-medical factors, conditions in which people are born, grow, live, and work in, more often than not, impact health outcomes more than the clinical care they receive. The post A Reality Check on SDOH: Challenges We Can’t Ignore appeared first on […]
  • by Stephanie Baum
    [Sponsored] The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today! The post Eliminating Blind Spots in the Patient Journey appeared first on MedCity News.
  • by Marissa Plescia
    Between 4.6 million and 5.2 million adults would lose Medicaid coverage in 2026 due to proposed work requirements, according to a new report. The post What Is the Economic Impact of Medicaid Work Requirements? appeared first on MedCity News.
  • by Frank Vinluan
    Johnson & Johnson’s gene therapy for X-linked retinal pigmentosa did not meet the main vision goal of a pivotal study. J&J secured full rights to the program from gene therapy biotech MeiraGtx in 2023. The post J&J Gene Therapy for Rare, Progressive Vision-Loss Disorder Fails Phase 3 Test appeared first on MedCity News.